Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sprinklr Inc - Ordinary Sh... | Thomas Ragy | Director | Sale of securities on an exchange or to another person at price $ 8.37 per share. | 01 Jul 2025 | 3,000,000 | 766,217 | - | 8.4 | 25,110,000 | Class A Common Stock |
Sprinklr Inc - Ordinary Sh... | Thomas Ragy | Director | 01 Jul 2025 | 3,000,000 | 20,561,365 | - | - | Class B Common Stock | ||
Sprinklr Inc - Ordinary Sh... | Ragy Thomas | Director | 01 Jul 2025 | 3,000,000 | 3,766,217 | - | - | Class A Common Stock | ||
Iris Energy Ltd | Daniel Roberts | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 1,793,392 | 14,989,696 | - | 0 | Ordinary Shares | |
Iris Energy Ltd | William Roberts | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 1,793,392 | 14,989,696 | - | 0 | Ordinary Shares | |
SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 954,869 | 0 (0%) | 2% | - | Common Stock | |
Harrow Health Inc | Mark L. Baum | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 889,500 | 889,500 | - | - | RSU | |
Outlook Therapeutics Inc | Robert Charles Jahr | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 800,000 | 800,000 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 769,804 | 0 | - | - | Stock Option (Right to Buy) | |
Robinhood Markets Inc - Or... | Vladimir Tenev | Director, Chief Executive Officer | 01 Jul 2025 | 750,000 | 47,367,360 | - | - | Class B Common Stock | ||
Robinhood Markets Inc - Or... | Vladimir Tenev | Director, Chief Executive Officer | 01 Jul 2025 | 750,000 | 750,000 | - | - | Class A Common Stock | ||
Robinhood Markets Inc - Or... | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 93.27 per share. | 01 Jul 2025 | 750,000 | 0 | - | 93.3 | 69,954,825 | Class A Common Stock |
SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 579,749 | 0 | - | - | Performance Share Units | |
Integral Ad Science Holdin... | Alpana Wegner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 525,279 | 525,279 | - | 0 | Common Stock, $0.001 par value | |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | 01 Jul 2025 | 490,560 | 48,024,933 | - | - | Class B Common Stock | ||
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | 01 Jul 2025 | 490,560 | 490,560 (0%) | 0% | - | Class A Common Stock | ||
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | 01 Jul 2025 | 490,560 | 490,560 (0%) | 0% | - | Class A Common Stock | ||
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | 01 Jul 2025 | 490,560 | 48,024,933 | - | - | Class B Common Stock | ||
Joby Aviation Inc | JoeBen Bevirt | Director, CEO and Chief Architect, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.82 per share. | 01 Jul 2025 | 472,000 | 360,999 | - | 9.8 | 4,635,040 | Common Stock |
SelectQuote Inc | William Grant | CHIEF OPERATING OFFICER | 01 Jul 2025 | 448,474 | 2,672,050 | - | 0 | Common Stock, par value $0.01 per share | ||
SelectQuote Inc | Grant Robert | PRESIDENT | 01 Jul 2025 | 448,474 | 2,464,408 | - | 0 | Common Stock, par value $0.01 per share | ||
Riot Platforms Inc | Stephen Howell | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 443,656 | 1,468,268 (5%) | 1% | 0 | Common Stock | |
Independent Bank Corp. | Kenneth S. Ansin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 432,481 | 432,481 (1%) | 1% | - | Common Stock | |
Harrow Health Inc | Andrew R. Boll | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 405,750 | 405,750 | - | - | RSU | |
Insperity Inc | Paul J. Sarvadi | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 400,000 | 400,000 | - | - | Performance-Based Stock Units | |
SpringWorks Therapeutics Inc | Perier Francis I. | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 368,923 | 0 | - | - | Stock Option (Right to Buy) | |
National Grid Plc - ADR | John Mark Pettigrew | Executive Director,Chief Executive Officer | 01 Jul 2025 | 350,958 | 2,284,972 (0%) | 0% | 0 | Ords | ||
SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 325,000 | 0 | - | - | Stock Option (Right to Buy) | |
Clover Health Investments ... | Andrew Toy | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 01 Jul 2025 | 308,950 | 10,560,047 | - | 2.8 | 849,613 | Class A Common Stock |
Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 01 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 01 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | Desantis Dean | Ten Percent Owner | 01 Jul 2025 | 300,000 | 7,500,000 (10%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | Milmoe William H. | Ten Percent Owner | 01 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | William Milmoe H. | Ten Percent Owner | 01 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 01 Jul 2025 | 300,000 | 7,800,000 (11%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 01 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | Desantis Dean | Ten Percent Owner | 01 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | H. Milmoe William | Ten Percent Owner | 01 Jul 2025 | 300,000 | 7,200,000 (10%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | Desantis Dean | Ten Percent Owner | 01 Jul 2025 | 300,000 | 7,200,000 (10%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | William Milmoe H. | Ten Percent Owner | 01 Jul 2025 | 300,000 | 7,800,000 (11%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 01 Jul 2025 | 300,000 | 7,500,000 (10%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Shutterstock Inc | Hennessy J. Paul | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 275,113 | 0 | - | - | Performance-based Restricted Stock Units | |
Shutterstock Inc | Paul Hennessy J. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 275,113 | 406,795 (1%) | 0% | 0 | Common Stock | |
SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 260,000 | 0 | - | - | Stock Option (Right to Buy) | |
Howmet Aerospace | John C. Plant | Director, Executive Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 255,363 | 2,449,034 (0%) | 0% | 0 | Common Stock | |
SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 250,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Badreddin Edris | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 240,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Lynch Daniel S. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 232,376 | 0 | - | - | Stock Option (Right to Buy) | |
Asana Inc - Ordinary Share... | Dustin Moskovitz | Director, President, CEO, & Chair, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.58 per share. | 01 Jul 2025 | 225,000 | 51,711,191 | - | 13.6 | 3,056,355 | Class A Common Stock |
Asana Inc - Ordinary Share... | Dustin Moskovitz | Director, President, CEO, & Chair, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.61 per share. | 01 Jul 2025 | 225,000 | 51,936,191 | - | 13.6 | 3,061,463 | Class A Common Stock |
Riot Platforms Inc | Stephen Howell | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 221,827 | 1,024,612 (4%) | 0% | 0 | Common Stock | |
Honest Company Inc (The ) | Curtiss Bruce | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 202,880 | 202,880 | - | 0 | Common Stock | |
Orion Energy Systems Inc | Sally Washlow | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 200,000 | 253,580 (0%) | 0% | 0 | Common Stock | |
National Grid Plc - ADR | Andy Agg | Executive Director,Chief Financial Officer | 01 Jul 2025 | 197,976 | 976,614 (0%) | 0% | 0 | Ords | ||
Southern States Bancshares... | Brian Stacy Holmes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 189,961 | 0 | - | - | Common Stock, par value $5.00 per share | |
SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 176,411 | 0 | - | - | Stock Option (Right to Buy) | |
Telos Corp | John B. Wood | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 3.12 per share. | 01 Jul 2025 | 172,212 | 5,262,033 | - | 3.1 | 537,301 | Common Stock |
SpringWorks Therapeutics Inc | Badreddin Edris | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 169,712 | 0 (0%) | 0% | - | Common Stock | |
National Grid Plc - ADR | John Mark Pettigrew | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.78 per share. | 01 Jul 2025 | 165,530 | 2,119,442 (0%) | 0% | 10.8 | 1,784,286 | Ords |
Orion Energy Systems Inc | Scott A. Green | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 150,000 | 1,372,262 (4%) | 0% | 0 | Common Stock | |
SpringWorks Therapeutics Inc | Badreddin Edris | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 149,470 | 0 | - | - | Stock Option (Right to Buy) | |
Shutterstock Inc | Paul Hennessy J. | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.10 per share. | 01 Jul 2025 | 137,340 | 269,455 (0%) | 0% | 20.1 | 2,760,534 | Common Stock |
Alector Inc | Arnon Rosenthal | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 137,125 | 2,551,782 (3%) | 0% | 0 | Common Stock | |
SpringWorks Therapeutics Inc | Cassidy James | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 135,000 | 0 | - | - | Stock Option (Right to Buy) | |
Riot Platforms Inc | Ryan D. Werner | SVP, CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 133,097 | 841,506 (3%) | 0% | 0 | Common Stock | |
SpringWorks Therapeutics Inc | S. Herschel Weinstein | General Counsel & Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Perier Francis I. | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
Riot Platforms Inc | Colin Yee | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 124,823 | 327,900 (1%) | 0% | 0 | Common Stock | |
SpringWorks Therapeutics Inc | Badreddin Edris | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 120,000 | 0 | - | - | Stock Option (Right to Buy) | |
Definitive Healthcare Corp... | Kevin D. Coop | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 01 Jul 2025 | 116,750 | 3,622,381 | - | 4.1 | 472,838 | Class A Common Stock |
Southern States Bancshares... | Mark A. Chambers | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 116,652 | 0 | - | - | Common Stock, par value $5.00 per share | |
Southern States Bancshares... | Greg B. Smith | Chief Risk Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 113,700 | 0 | - | - | Common Stock, par value $5.00 per share | |
SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 109,329 | 0 | - | - | Stock Option (Right to Buy) | |
Independent Bank Corp. | Kenneth S. Ansin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 106,738 | 106,738 (0%) | 0% | - | Common Stock | |
SpringWorks Therapeutics Inc | Weinstein Herschel S. | General Counsel & Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 106,600 | 0 | - | - | Stock Option (Right to Buy) | |
RenovoRx Inc | Shaun R. Bagai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 102,498 | 102,498 | - | - | Stock Option | |
Southern States Bancshares... | Jay Florey Pumroy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 101,679 | 0 | - | - | Common Stock, par value $5.00 per share | |
Riot Platforms Inc | Jason Les | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.27 per share. | 01 Jul 2025 | 101,610 | 7,253,244 (29%) | 0% | 11.3 | 1,145,145 | Common Stock |
Insperity Inc | A. Steve Arizpe | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 100,000 | 100,000 | - | - | Performance-Based Stock Units | |
Orion Energy Systems Inc | J. Per Brodin | EVP, CFO, CAO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 100,000 | 923,113 (3%) | 0% | 0 | Common Stock | |
Clarivate Plc | Gordon Samson | President, IP | Sale of securities on an exchange or to another person at price $ 4.53 per share. | 01 Jul 2025 | 100,000 | 1,271,103 | - | 4.5 | 453,000 | Ordinary Shares |
Celsius Holdings Inc | Milmoe H. William | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.50 per share. | 01 Jul 2025 | 100,000 | 18,217,770 (26%) | 0% | 47.5 | 4,750,000 | Common Stock |
Celsius Holdings Inc | Milmoe H. William | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.30 per share. | 01 Jul 2025 | 100,000 | 18,117,770 (26%) | 0% | 47.3 | 4,730,000 | Common Stock |
Celsius Holdings Inc | H. William Milmoe | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.00 per share. | 01 Jul 2025 | 100,000 | 18,017,770 (26%) | 0% | 47 | 4,700,000 | Common Stock |
SpringWorks Therapeutics Inc | Edris Badreddin | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Bhavesh Ashar | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
SRM Entertainment Inc | Richard A. Miller | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 100,000 | 65,000 | - | - | Stock option (right to buy) | |
SRM Entertainment Inc | Richard A. Miller | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.56 per share. | 01 Jul 2025 | 100,000 | 900,000 | - | 0.6 | 56,000 | Common Stock |
Immersion Corp | Eric B. Singer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.91 per share. | 01 Jul 2025 | 98,375 | 1,981,592 (6%) | 0% | 7.9 | 778,146 | Common Stock |
Virtu Financial Inc - Ordi... | Joseph Molluso | Co-President & Co-COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 98,199 | 0 | - | - | Deferred Stock Unit | |
Virtu Financial Inc - Ordi... | Joseph Molluso | Co-President & Co-COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 98,199 | 528,144 (0%) | 0% | - | Class A common stock | |
Veritex Holdings Inc | Terry S. Earley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 97,204 | 245,259 (0%) | 0% | 0 | Common Stock | |
Veritex Holdings Inc | Terry S. Earley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 97,204 | 0 | - | - | Restricted Stock Unit | |
National Grid Plc - ADR | Andy Agg | Executive Director,Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.78 per share. | 01 Jul 2025 | 93,376 | 883,238 (0%) | 0% | 10.8 | 1,006,521 | Ords |
SpringWorks Therapeutics Inc | Lynch S. Daniel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 93,004 | 0 (0%) | 0% | - | Common Stock | |
Arlo Technologies Inc | Kurtis J. Binder | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 17.17 per share. | 01 Jul 2025 | 92,247 | 923,527 (1%) | 0% | 17.2 | 1,583,613 | Common Stock |
Dropbox Inc - Ordinary Sha... | Andrew W. Houston | Director, Chief Executive Officer, Ten Percent Owner | 01 Jul 2025 | 92,000 | 92,000 (0%) | 0% | 0 | Class A Common Stock | ||
Dropbox Inc - Ordinary Sha... | Andrew W. Houston | Director, Chief Executive Officer, Ten Percent Owner | 01 Jul 2025 | 92,000 | 67,467,629 | - | - | Class B Common Stock | ||
Dropbox Inc - Ordinary Sha... | Andrew W. Houston | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.96 per share. | 01 Jul 2025 | 92,000 | 0 (0%) | 0% | 28.0 | 2,571,998 | Class A Common Stock |
Gamestop Corporation - Ord... | Mark H. Robinson | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 27.34 per share. | 01 Jul 2025 | 91,442 | 129,105 (0%) | 0% | 27.3 | 2,500,024 | Class A Common Stock |
Independent Bank Corp. | Kenneth S. Ansin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 90,894 | 90,894 (0%) | 0% | - | Common Stock | |
Iron Mountain - REIT | Bailey H Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 90,860 | 242,454 (0%) | 0% | 0 | Common Stock | |
Iron Mountain - REIT | Bailey H Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 90,860 | 0 | - | - | Phantom Stock | |
Shutterstock Inc | J. Hennessy Paul | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 87,597 | 357,052 (1%) | 0% | 0 | Common Stock | |
Shutterstock Inc | J. Paul Hennessy | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 87,597 | 0 | - | - | Restricted Stock Unit | |
Telos Corp | Gary Mark Bendza | EVP, CFO | Grant, award, or other acquisition of securities at price $ 3.12 per share. | 01 Jul 2025 | 85,997 | 779,805 | - | 3.1 | 268,311 | Common Stock |
Riot Platforms Inc | Colin Yee | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 83,752 | 1,957,513 | - | - | Restricted Stock Units | |
SpringWorks Therapeutics Inc | James Cassidy | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 81,731 | 0 (0%) | 0% | - | Common Stock | |
SpringWorks Therapeutics Inc | Cassidy James | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 80,000 | 0 | - | - | Stock Option (Right to Buy) | |
Tenax Therapeutics Inc | Proehl Gerald T. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
Tenax Therapeutics Inc | Michael Davidson Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
Tenax Therapeutics Inc | S. June Almenoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
Tenax Therapeutics Inc | Doogan Declan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
Tenax Therapeutics Inc | M Robyn Hunter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
Local Bounti Corp - Ordina... | Valiasek Kathleen | President, CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 01 Jul 2025 | 79,021 | 1,728,097 | - | 2.4 | 190,441 | Common Stock |
SpringWorks Therapeutics Inc | Edris Badreddin | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 78,960 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Nofi Michael P. | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 78,300 | 0 | - | - | Stock Option (Right to Buy) | |
Telos Corp | John B. Wood | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. | 01 Jul 2025 | 77,668 | 5,184,365 | - | 3.1 | 242,324 | Common Stock |
SpringWorks Therapeutics Inc | I. Francis Perier | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 75,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Ashar Bhavesh | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 75,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Lin Tai-An | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 75,000 | 0 | - | - | Stock Option (Right to Buy) | |
Affiliated Managers Group ... | Jay C. Horgen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.49 per share. | 01 Jul 2025 | 75,000 | 516,120 (1%) | 0% | 74.5 | 5,586,750 | Common Stock |
Affiliated Managers Group ... | Jay C. Horgen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 75,000 | 225,000 | - | - | Employee Stock Option (Right to Buy) | |
Workday | David A. Duffield | Ten Percent Owner | 01 Jul 2025 | 72,917 | 175,914 (0%) | 0% | 0 | Class A Common Stock | ||
Workday | David A. Duffield | Ten Percent Owner | 01 Jul 2025 | 72,917 | 41,993,734 | - | - | Class B Common Stock | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 72,680 | 0 | - | - | Stock Option (Right to Buy) | |
UiPath Inc - Ordinary Shar... | Ashim Gupta | COO & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.80 per share. | 01 Jul 2025 | 71,009 | 916,313 | - | 12.8 | 908,915 | Class A Common Stock |
SpringWorks Therapeutics Inc | Bhavesh Ashar | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 70,000 | 0 | - | - | Stock Option (Right to Buy) | |
Rush Street Interactive In... | Einar Roosileht | Chief Information Officer | 01 Jul 2025 | 70,000 | 2,324,157 | - | - | Class A Common Units of Rush Street Interactive, L.P. | ||
Rush Street Interactive In... | Einar Roosileht | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 14.77 per share. | 01 Jul 2025 | 70,000 | 876,150 | - | 14.8 | 1,033,760 | Class A Common Stock |
Rush Street Interactive In... | Einar Roosileht | Chief Information Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 70,000 | 2,324,157 | - | 0 | Class V Voting Stock | |
Rush Street Interactive In... | Einar Roosileht | Chief Information Officer | 01 Jul 2025 | 70,000 | 946,150 | - | 0 | Class A Common Stock | ||
Iron Mountain - REIT | William L. Meaney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 69,125 | 345,625 | - | - | Employee Stock Option (Right to Buy) | |
Iron Mountain - REIT | William L. Meaney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.59 per share. | 01 Jul 2025 | 69,125 | 69,125 (0%) | 0% | 36.6 | 2,529,146 | Common Stock, par value $.01 per share |
Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.91 per share. | 01 Jul 2025 | 68,400 | 1,352,900 (4%) | 0% | 7.9 | 541,044 | Common Stock |
Telos Corp | Mark D. Griffin | EVP, Security Solutions | Grant, award, or other acquisition of securities at price $ 3.12 per share. | 01 Jul 2025 | 67,642 | 1,030,900 | - | 3.1 | 211,043 | Common Stock |
Evolent Health Inc - Ordin... | Seth Blackley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 67,150 | 829,367 (0%) | 0% | 0 | Class A Common Stock | |
Riot Platforms Inc | Ryan D. Werner | SVP, CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 66,548 | 708,409 (2%) | 0% | 0 | Common Stock | |
PubMatic Inc - Ordinary Sh... | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 65,516 | 65,516 | - | 0 | Class A Common Stock | |
SpringWorks Therapeutics Inc | P. Nofi Michael | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 65,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 65,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 64,000 | 0 | - | - | Stock Option (Right to Buy) | |
RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 63,636 | 63,636 | - | - | Stock Option | |
PBF Energy Inc - Ordinary ... | Thomas J. Nimbley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.27 per share. | 01 Jul 2025 | 62,721 | 786,692 (0%) | 0% | 22.3 | 1,396,797 | Class A Common Stock |
Krispy Kreme Inc | P. McBride Kelly | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 62,696 | 149,147 | - | 0 | Common Stock | |
SpringWorks Therapeutics Inc | Bhavesh Ashar | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 62,053 | 0 (0%) | 0% | - | Common Stock | |
Wayfair Inc - Ordinary Sha... | Fiona Tan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 60,990 | 173,753 (0%) | 0% | 0 | Class A Common Stock | |
Wayfair Inc - Ordinary Sha... | Fiona Tan | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 60,990 | 0 | - | - | Restricted Stock Unit ("RSU") | |
SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 60,889 | 0 (0%) | 0% | - | Common Stock | |
SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | S. Herschel Weinstein | General Counsel & Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
PureTech Health Plc - ADR | John L. LaMattina | Non-Executive Director | 01 Jul 2025 | 59,202 | 1,543,494 (0%) | 0% | 0 | Ords 0.01p | ||
PureTech Health Plc - ADR | Robert S. Langer | Director | 01 Jul 2025 | 59,202 | 3,053,155 (1%) | 0% | 0 | Ords 0.01p | ||
PureTech Health Plc - ADR | Raju S. Kucherlapati | Chairman of the Board | 01 Jul 2025 | 59,202 | 2,568,852 (1%) | 0% | 0 | Ords 0.01p | ||
PureTech Health Plc - ADR | Kiran Mazumdar Shaw | Non-Executive Director | 01 Jul 2025 | 59,202 | 109,021 (0%) | 0% | 0 | Ords 0.01p | ||
PureTech Health Plc - ADR | Sharon Barber-Lui | Independent Director | 01 Jul 2025 | 59,202 | 97,831 (0%) | 0% | 0 | Ords 0.01p | ||
MagnaChip Semiconductor Corp | Lee Ilbok | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 55,845 | 275,026 (0%) | 0% | 0 | Common Stock | |
SpringWorks Therapeutics Inc | Weinstein Herschel S. | General Counsel & Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 55,239 | 0 (0%) | 0% | - | Common Stock | |
Insight Molecular Diagnost... | Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 55,000 | 136,554 (0%) | 0% | 0 | Common Stock, no par value | |
Alector Inc | Saraswati Kenkare-Mitra | President and Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 54,725 | 566,977 (0%) | 0% | 0 | Common Stock | |
Iron Mountain - REIT | William L. Meaney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 100.14 per share. | 01 Jul 2025 | 54,162 | 14,963 (0%) | 0% | 100.1 | 5,423,566 | Common Stock, par value $.01 per share |
MagnaChip Semiconductor Corp | Camillo Martino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 53,247 | 229,127 (0%) | 0% | 0 | Common Stock | |
Korn Ferry | Gary D. Burnison | Director, CEO | Sale of securities on an exchange or to another person at price $ 73.86 per share. | 01 Jul 2025 | 53,173 | 219,945 (0%) | 0% | 73.9 | 3,927,592 | Common Stock, par value $0.01 per share |
Southern States Bancshares... | J. Henry Smith | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 52,725 | 0 | - | - | Common Stock, par value $5.00 per share | |
Virtu Financial Inc - Ordi... | Joseph Molluso | Co-President & Co-COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jul 2025 | 51,997 | 476,147 (0%) | 0% | - | Class A common stock | |
Wayfair Inc - Ordinary Sha... | Jon Blotner | Pres., Commercial & Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 51,305 | 0 | - | - | Restricted Stock Unit ("RSU") | |
Wayfair Inc - Ordinary Sha... | Jon Blotner | Pres., Commercial & Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 51,305 | 130,222 (0%) | 0% | 0 | Class A Common Stock | |
Amplify Energy Corp. | Christopher W. Hamm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 51,043 | 51,043 | - | - | Restricted Stock Units | |
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 50,762 | 0 (0%) | 0% | - | Common Stock | |
MagnaChip Semiconductor Corp | E. Nathan Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 50,650 | 206,693 (0%) | 0% | 0 | Common Stock | |
SpringWorks Therapeutics Inc | Cassidy James | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 50,615 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Ashar Bhavesh | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 50,615 | 0 | - | - | Stock Option (Right to Buy) | |
Wayfair Inc - Ordinary Sha... | Kate Gulliver | CFO and Chief Admin Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 50,604 | 0 | - | - | Restricted Stock Unit ("RSU") | |
Wayfair Inc - Ordinary Sha... | Kate Gulliver | CFO and Chief Admin Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 50,604 | 196,395 (0%) | 0% | 0 | Class A Common Stock | |
Taboola.com Ltd | Adam Singolda | Director, Founder and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.66 per share. | 01 Jul 2025 | 50,302 | 16,245,346 | - | 3.7 | 184,105 | Ordinary Shares |
Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 01 Jul 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 50,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 106.97 per share. | 01 Jul 2025 | 50,000 | 178,342 (0%) | 0% | 107.0 | 5,348,315 | Common Stock |
Warby Parker Inc - Ordinar... | David Gilboa | Director, Co-Chief Executive Officer | 01 Jul 2025 | 50,000 | 5,367,917 | - | - | Class B Common Stock | ||
Warby Parker Inc - Ordinar... | David Gilboa | Director, Co-Chief Executive Officer | 01 Jul 2025 | 50,000 | 78,475 | - | 0 | Class A Common Stock | ||
Warby Parker Inc - Ordinar... | David Gilboa | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.04 per share. | 01 Jul 2025 | 50,000 | 28,475 | - | 22.0 | 1,102,000 | Class A Common Stock |
Starz Entertainment Corp. | Jeffrey A. Hirsch | Director, SEE REMARKS | Sale or transfer of securities back to the company at price $ 15.82 per share. | 01 Jul 2025 | 49,928 | 194,002 | - | 15.8 | 789,861 | Common Shares |
Joby Aviation Inc | JoeBen Bevirt | Director, CEO and Chief Architect, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 49,801 | 423,778 | - | 0 | Common Stock | |
Joby Aviation Inc | JoeBen Bevirt | Director, CEO and Chief Architect, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 49,801 | 99,602 | - | - | Restricted Stock Units (RSUs) | |
Longeveron Inc - Ordinary ... | Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 49,219 | 49,219 | - | - | Stock Option (right to buy) | |
Iris Energy Ltd | David Bartholomew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 48,960 | 145,205 | - | 0 | Ordinary Shares | |
Telos Corp | Edward Hutchinson Robbins | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 3.12 per share. | 01 Jul 2025 | 48,140 | 453,697 | - | 3.1 | 150,197 | Common Stock |
Affiliated Managers Group ... | Jay C. Horgen | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 198.72 per share. | 01 Jul 2025 | 47,191 | 468,929 (0%) | 0% | 198.7 | 9,377,796 | Common Stock |
MeridianLink Inc | Laurence E. Katz | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.23 per share. | 01 Jul 2025 | 46,948 | 1,237,423 | - | 16.2 | 761,966 | Common Stock, par value $0.001 |
Workday | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 239.08 per share. | 01 Jul 2025 | 46,591 | 110,930 (0%) | 0% | 239.1 | 11,138,995 | Class A Common Stock |
ClearSign Technologies Corp | Judith S. Schrecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 46,296 | 431,957 | - | - | Restricted Stock Units | |
Agilon Health Inc | Jeffrey Schwaneke A. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.38 per share. | 01 Jul 2025 | 46,099 | 1,075,122 | - | 2.4 | 109,716 | Common Stock |
Alector Inc | Arnon Rosenthal | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 45,700 | 45,700 | - | - | Employee Stock Option (right to buy) | |
Postal Realty Trust Inc - ... | B. Robert Klein | Principal Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 45,698 | 67,019 | - | - | LTIP Units | |
MagnaChip Semiconductor Corp | Kyo-Hwa Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 45,455 | 94,683 (0%) | 0% | 0 | Common Stock | |
DoorDash | Stanley Tang | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2025 | 45,410 | 45,410 | - | 0 | Class A Common Stock | |
DoorDash | Stanley Tang | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2025 | 45,410 | 3,945,041 | - | - | Class B Common Stock | |
UiPath Inc - Ordinary Shar... | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.84 per share. | 01 Jul 2025 | 45,000 | 5,508,376 | - | 12.8 | 577,971 | Class A Common Stock |
Evolent Health Inc - Ordin... | Daniel McCarthy | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 44,767 | 433,771 (0%) | 0% | 0 | Class A Common Stock | |
Shutterstock Inc | J. Paul Hennessy | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.10 per share. | 01 Jul 2025 | 44,719 | 312,333 (0%) | 0% | 20.1 | 898,852 | Common Stock |
Starz Entertainment Corp. | Hirsch A. Jeffrey | Director, SEE REMARKS | Sale or transfer of securities back to the company at price $ 16.07 per share. | 01 Jul 2025 | 44,577 | 243,930 | - | 16.1 | 716,352 | Common Shares |
Vimeo Inc | Alexander von Furstenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 44,444 | 240,489 | - | - | Common Stock | |
Vimeo Inc | Jay Herratti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 44,444 | 168,148 | - | - | Common Stock | |
Vimeo Inc | Adam Cahan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 44,444 | 44,444 | - | - | Common Stock | |
Vimeo Inc | Lydia Jett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 44,444 | 44,444 | - | - | Common Stock | |
Vimeo Inc | Adam Gross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 44,444 | 328,322 | - | - | Common Stock | |
Vimeo Inc | Mo Koyfman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 44,444 | 218,969 | - | - | Common Stock | |
Vimeo Inc | Kirsten Marie Kliphouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 44,444 | 44,444 | - | - | Common Stock | |
Postal Realty Trust Inc - ... | Klein Robert B. | Principal Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 43,038 | 23,981 | - | - | LTIP Units | |
NetApp | George Kurian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 42,909 | 42,909 | - | - | Restricted Stock Unit | |
Veritex Holdings Inc | Terry S. Earley | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.87 per share. | 01 Jul 2025 | 42,485 | 202,774 (0%) | 0% | 26.9 | 1,141,572 | Common Stock |
Amplify Energy Corp. | Clint Coghill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 41,922 | 41,922 | - | - | Restricted Stock Units | |
RenovoRx Inc | Ronald B. Kocak | VP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 41,600 | 41,600 | - | - | Stock Option | |
Vestis Corp | Laveck John | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 41,119 | 41,119 | - | 0 | Common Stock, par value $0.01 per share | |
Riot Platforms Inc | Colin Yee | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 41,071 | 2,041,265 | - | - | Restricted Stock Units | |
Local Bounti Corp - Ordina... | Hurlbert Craig M. | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 01 Jul 2025 | 40,786 | 948,810 | - | 2.4 | 98,294 | Common Stock |
SpringWorks Therapeutics Inc | P. Michael Nofi | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 40,000 | 0 | - | - | Stock Option (Right to Buy) | |
SiteOne Landscape Supply Inc | Ketter Joseph | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 39,640 | 0 | - | - | Stock Options (right to buy) | |
SiteOne Landscape Supply Inc | Joseph Ketter | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.84 per share. | 01 Jul 2025 | 39,640 | 53,303 (0%) | 0% | 12.8 | 508,978 | Common Stock |
SiteOne Landscape Supply Inc | Joseph Ketter | EVP, Human Resources | Sale of securities on an exchange or to another person at price $ 126.28 per share. | 01 Jul 2025 | 39,640 | 13,663 (0%) | 0% | 126.3 | 5,005,739 | Common Stock |
Iris Energy Ltd | Christopher Guzowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 39,168 | 51,126 | - | 0 | Ordinary Shares | |
TransUnion | Alicia Brooke Zuiker | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 38,932 | 38,932 (0%) | 0% | 0 | Common Stock | |
Telos Corp | Gary Mark Bendza | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. | 01 Jul 2025 | 38,785 | 741,020 | - | 3.1 | 121,009 | Common Stock |
Palo Alto | Zuk Nir | Director, EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 197.69 per share. | 01 Jul 2025 | 38,101 | 3,288,115 (3%) | 0% | 197.7 | 7,532,072 | Common Stock |
Krispy Kreme Inc | Bernardo Hees | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 37,618 | 702,728 | - | 0 | Common Stock | |
Krispy Kreme Inc | Patricia Capel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 37,618 | 91,747 | - | 0 | Common Stock | |
Roblox Corporation - Ordin... | Anthony P. Lee | Director | Sale of securities on an exchange or to another person at price $ 103.60 per share. | 01 Jul 2025 | 37,466 | 6,747,165 | - | 103.6 | 3,881,545 | Class A Common Stock |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 37,455 | 0 | - | - | Stock Option (Right to Buy) | |
Vertex Pharma | Stuart A. Arbuckle | EVP, COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 450.23 per share. | 01 Jul 2025 | 37,243 | 63,368 (0%) | 0% | 450.2 | 16,767,916 | Common Stock |
Barrett Business Services ... | Gary E. Kramer | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 36,887 | 36,887 | - | - | Restricted Stock Units | |
Amplify Energy Corp. | Todd R. Snyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 36,459 | 36,459 | - | - | Restricted Stock Units | |
Amplify Energy Corp. | Deborah G. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 36,459 | 36,459 | - | - | Restricted Stock Units | |
KeyCorp | Barbara Snyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 35,955 | 71,632 (0%) | 0% | - | Common Shares | |
KeyCorp | Barbara Snyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 35,955 | 177,901 | - | - | Deferred Shares | |
Grid Dynamics Holdings Inc... | Leonard Livschitz | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.87 per share. | 01 Jul 2025 | 35,901 | 2,927,279 | - | 11.9 | 426,145 | Common Stock |
Extreme Networks Inc. | Edward B. Meyercord | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 35,725 | 460,298 | - | - | Non-Qualified Stock Option (right to buy) | |
Extreme Networks Inc. | Edward B. Meyercord | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 01 Jul 2025 | 35,725 | 1,541,282 (1%) | 0% | 18.2 | 650,506 | Common Stock |
Extreme Networks Inc. | Edward B. Meyercord | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.70 per share. | 01 Jul 2025 | 35,725 | 1,577,007 (1%) | 0% | 6.7 | 239,358 | Common Stock |
Performance Food Group Com... | George L. Holm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.00 per share. | 01 Jul 2025 | 35,436 | 1,595,502 (1%) | 0% | 19 | 673,284 | Common Stock |
Performance Food Group Com... | George L. Holm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 35,436 | 70,872 | - | - | Options (Right to Buy) | |
SpringWorks Therapeutics Inc | S. Herschel Weinstein | General Counsel & Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 35,431 | 0 | - | - | Stock Option (Right to Buy) | |
Insight Molecular Diagnost... | Silverman Louis E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 35,000 | 36,564 (0%) | 0% | 0 | Common Stock, no par value | |
Insight Molecular Diagnost... | Last J. Andrew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 35,000 | 39,509 (0%) | 0% | 0 | Common Stock, no par value | |
ClearSign Technologies Corp | Lou Basenese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 34,722 | 45,645 | - | - | Restricted Stock Units | |
SpringWorks Therapeutics Inc | Francis I. Perier | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 34,419 | 0 | - | - | Stock Option (Right to Buy) | |
MeridianLink Inc | Nicolaas Vlok | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.23 per share. | 01 Jul 2025 | 34,316 | 1,243,254 | - | 16.2 | 556,949 | Common Stock, par value $0.001 |
DoorDash | Tony Xu | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.16 per share. | 01 Jul 2025 | 34,167 | 554,617 | - | 7.2 | 244,636 | Class A Common Stock |
DoorDash | Tony Xu | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 34,167 | 1,541,639 | - | - | Stock Option (right to buy) | |
SpringWorks Therapeutics Inc | Badreddin Edris | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 33,778 | 0 | - | - | Performance Share Units | |
Valley National Bancorp | Lyndsey M. Sloan | SEVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 33,595 | 33,595 (0%) | 0% | 0 | Common Stock | |
Zspace Inc | Paul Kellenberger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 33,500 | 33,500 | - | 0 | Common Stock | |
Zspace Inc | Paul Kellenberger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 33,500 | 234,000 | - | - | Restricted Stock Units | |
Landbridge Company LLC. - ... | Jason Long | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.38 per share. | 01 Jul 2025 | 33,424 | 221,403 | - | 66.4 | 2,218,685 | Class A shares |
Palantir | Ryan Taylor | See Remarks | Sale of securities on an exchange or to another person at price $ 135.31 per share. | 01 Jul 2025 | 33,335 | 363,755 | - | 135.3 | 4,510,452 | Class A Common Stock |
Palantir | Taylor Ryan | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.72 per share. | 01 Jul 2025 | 33,335 | 397,090 | - | 4.7 | 157,341 | Class A Common Stock |
Palantir | Ryan Taylor | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 33,335 | 33,335 | - | - | Employee Stock Option (Right to buy) | |
PMV Pharmaceuticals Inc | Deepika Jalota | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 01 Jul 2025 | 33,065 | 89,959 | - | 1.1 | 35,198 | Common Stock |
SpringWorks Therapeutics Inc | Lin Tai-An | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 33,039 | 0 (0%) | 0% | - | Common Stock | |
PubMatic Inc - Ordinary Sh... | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.56 per share. | 01 Jul 2025 | 33,001 | 32,515 | - | 12.6 | 414,601 | Class A Common Stock |
ClearSign Technologies Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 32,638 | 93,639 | - | - | Restricted Stock Units | |
Wayfair Inc - Ordinary Sha... | Fiona Tan | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.99 per share. | 01 Jul 2025 | 32,428 | 141,325 (0%) | 0% | 52.0 | 1,685,932 | Class A Common Stock |
Joby Aviation Inc | JoeBen Bevirt | Director, CEO and Chief Architect, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.82 per share. | 01 Jul 2025 | 32,285 | 391,493 | - | 9.8 | 317,039 | Common Stock |
SIGA Technologies Inc | Dennis E. Hruby | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 32,258 | 201,514 (0%) | 0% | 0 | Common Stock, par value $.0001 per share | |
SIGA Technologies Inc | Dennis E. Hruby | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 32,258 | 0 | - | - | Restricted Stock Units | |
ClearSign Technologies Corp | Catharine de Lacy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 32,175 | 218,957 | - | - | Restricted Stock Units | |
Vuzix Corporation | Timothy Harned Boris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 31,746 | 328,158 (0%) | 0% | 0 | Common Stock | |
Vuzix Corporation | Kay W. Edward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 31,746 | 309,511 (0%) | 0% | 0 | Common Stock | |
Vuzix Corporation | Paula Whitten-Doolin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 31,746 | 122,668 (0%) | 0% | 0 | Common Stock | |
PubMatic Inc - Ordinary Sh... | Steven Pantelick | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 30,964 | 57,990 | - | 0 | Class A Common Stock | |
ZoomInfo Technologies Inc. | James Roth | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 30,638 | 63,095 | - | - | Common Stock | |
ZoomInfo Technologies Inc. | James Roth | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 30,638 | 153,193 | - | - | Restricted Stock Units | |
SpringWorks Therapeutics Inc | Nofi Michael P. | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 30,623 | 0 (0%) | 0% | - | Common Stock | |
Cushman & Wakefield plc | Noelle Perkins | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 30,562 | 30,563 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Noelle Perkins | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 30,562 | 62,377 (0%) | 0% | 0 | Ordinary Shares | |
Telos Corp | Mark D. Griffin | EVP, Security Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. | 01 Jul 2025 | 30,507 | 1,000,393 | - | 3.1 | 95,182 | Common Stock |
SpringWorks Therapeutics Inc | Carlos Alban | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 30,160 | 0 | - | - | Stock Option (Right to Buy) | |
Mr. Cooper Group Inc | Jay Bray | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 152.14 per share. | 01 Jul 2025 | 30,000 | 693,187 (0%) | 0% | 152.1 | 4,564,200 | Common Stock |
MGIC Investment Corp | Salvatore A. Miosi | President & COO | Sale of securities on an exchange or to another person at price $ 28.15 per share. | 01 Jul 2025 | 30,000 | 279,401 (0%) | 0% | 28.2 | 844,560 | Common Stock |
DoorDash | Andy Fang | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2025 | 30,000 | 6,129,604 | - | - | Class B Common Stock | |
DoorDash | Andy Fang | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2025 | 30,000 | 30,000 | - | 0 | Class A Common Stock | |
Expensify Inc - Ordinary S... | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.56 per share. | 01 Jul 2025 | 30,000 | 1,528,480 | - | 2.6 | 76,800 | Class A Common Stock |
Ford Motor | Andrew Frick | President, Ford Blue & Model e | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 01 Jul 2025 | 30,000 | 113,939 (0%) | 0% | 11 | 330,000 | Common Stock, $0.01 par value |
Ford Motor | Andrew Frick | President, Ford Blue & Model e | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 01 Jul 2025 | 30,000 | 83,939 (0%) | 0% | 11.5 | 345,000 | Common Stock, $0.01 par value |
SpringWorks Therapeutics Inc | C. Freda Lewis-Hall | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 29,983 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Fuhrman Alan | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 29,983 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Lynch Daniel S. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 29,983 | 0 | - | - | Stock Option (Right to Buy) | |
ZoomInfo Technologies Inc. | James Roth | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.12 per share. | 01 Jul 2025 | 29,504 | 55,650 | - | 10.1 | 298,580 | Common Stock |
SpringWorks Therapeutics Inc | Martin Mackay W. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 29,445 | 0 | - | - | Stock Option (Right to Buy) | |
OP Bancorp | Sang Kyo Oh | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 29,326 | 29,326 | - | - | Restricted Stock Unit | |
Arq Inc | Jeremy Blank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 29,104 | 78,762 (0%) | 0% | 0 | Common Stock | |
Arq Inc | Richard M. Campbell-Breeden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 29,104 | 86,868 (0%) | 0% | 0 | Common Stock | |
Integral Ad Science Holdin... | Lisa Utzschneider | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 28,879 | 378,453 | - | 0 | Common Stock, $0.001 par value | |
Integral Ad Science Holdin... | Lisa Utzschneider | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 28,879 | 882,401 | - | - | Market Stock Units | |
SpringWorks Therapeutics Inc | Alban Carlos | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 28,861 | 0 (0%) | 0% | - | Common Stock | |
Pagaya Technologies Ltd - ... | Tami Rosen | Director, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 28,466 | 0 | - | - | Restricted Stock Unit | |
Pagaya Technologies Ltd - ... | Tami Rosen | Director, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 28,466 | 64,085 | - | 0 | Class A Ordinary Share | |
PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 01 Jul 2025 | 28,249 | 60,146 | - | 1.1 | 30,077 | Common Stock |
Korn Ferry | Gary D. Burnison | Director, CEO | Sale of securities on an exchange or to another person at price $ 74.21 per share. | 01 Jul 2025 | 28,058 | 173,118 (0%) | 0% | 74.2 | 2,082,246 | Common Stock, par value $0.01 per share |
FiscalNote Holdings Inc - ... | Timothy Hwang | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 01 Jul 2025 | 27,952 | 2,765,810 | - | 0.7 | 18,239 | Class A Common Stock |
Global Business Travel Gro... | Karen Williams | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.34 per share. | 01 Jul 2025 | 27,900 | 624,937 | - | 6.3 | 176,886 | Class A Common Stock |
M&T Bank | Rene F. Jones | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.47 per share. | 01 Jul 2025 | 27,733 | 116,883 (0%) | 0% | 132.5 | 3,673,791 | Common Stock |
M&T Bank | Rene F. Jones | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 27,733 | 0 | - | - | Option (right to buy) | |
Amplify Energy Corp. | Christopher W. Hamm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 27,531 | 0 | - | - | Restricted Stock Units | |
Amplify Energy Corp. | Christopher W. Hamm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 27,531 | 272,078 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
Aware Inc. | Brent P. Johnstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 27,349 | 244,304 (1%) | 0% | 0 | Common Stock | |
Netflix | Reed Hastings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 107.64 per share. | 01 Jul 2025 | 26,513 | 26,907 (0%) | 0% | 107.6 | 2,853,859 | Common Stock |
Netflix | Reed Hastings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 26,513 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Biodesix Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 26,368 | 310,135 | - | - | Common Stock | |
Biodesix Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 26,368 | 0 | - | - | Restricted Stock Units | |
Performance Food Group Com... | George L. Holm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 88.28 per share. | 01 Jul 2025 | 26,365 | 1,569,137 (1%) | 0% | 88.3 | 2,327,502 | Common Stock |
UiPath Inc - Ordinary Shar... | Hitesh Ramani | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.80 per share. | 01 Jul 2025 | 26,057 | 288,834 | - | 12.8 | 333,530 | Class A Common Stock |
Enhabit Inc | Barbara A. Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.88 per share. | 01 Jul 2025 | 25,957 | 552,754 | - | 7.9 | 204,541 | Common Stock |
Semtech Corp. | Hong Q. Hou | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 25,934 | 41,539 (0%) | 0% | 0 | Common Stock | |
Semtech Corp. | Hong Q. Hou | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 25,934 | 51,866 | - | - | Restricted Stock Unit | |
Aware Inc. | Brian D. Connolly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 25,671 | 218,784 (1%) | 0% | 0 | Common Stock | |
Southern States Bancshares... | Richard E. Drews | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 25,524 | 0 | - | - | Common Stock, par value $5.00 per share | |
Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,461 | 309,245 (0%) | 0% | 0 | Class A Common Stock | |
InnovAge Holding Corp | James G. Carlson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,316 | 87,350 | - | 0 | Common Stock, $0.001 par value | |
InnovAge Holding Corp | John Ellis Bush | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,316 | 45,157 | - | 0 | Common Stock, $0.001 par value | |
InnovAge Holding Corp | Marilyn B. Tavenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,316 | 45,157 | - | 0 | Common Stock, $0.001 par value | |
InnovAge Holding Corp | Richard C. Zoretic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,316 | 93,810 | - | 0 | Common Stock, $0.001 par value | |
InnovAge Holding Corp | Teresa F. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,316 | 59,126 | - | 0 | Common Stock, $0.001 par value | |
InnovAge Holding Corp | Patricia Fontneau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,316 | 62,125 | - | 0 | Common Stock, $0.001 par value | |
Wayfair Inc - Ordinary Sha... | Kate Gulliver | CFO and Chief Admin Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.99 per share. | 01 Jul 2025 | 25,106 | 171,289 (0%) | 0% | 52.0 | 1,305,261 | Class A Common Stock |
Wayfair Inc - Ordinary Sha... | Jon Blotner | Pres., Commercial & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.99 per share. | 01 Jul 2025 | 25,102 | 105,120 (0%) | 0% | 52.0 | 1,305,053 | Class A Common Stock |
Oruka Therapeutics Inc. | Laura Lee Sandler | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
Coinbase Global Inc - Ordi... | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | 01 Jul 2025 | 25,000 | 23,456,225 | - | - | Class B Common Stock | ||
Coinbase Global Inc - Ordi... | Armstrong Brian | Director, Chairman and CEO, Ten Percent Owner | 01 Jul 2025 | 25,000 | 25,526 | - | 0 | Class A Common Stock | ||
LifeMD Inc | Schreiber Justin | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 13.38 per share. | 01 Jul 2025 | 25,000 | 2,500,721 | - | 13.4 | 334,458 | Common Stock |
EverCommerce Inc | Matthew David Feiersrtein | President | Sale of securities on an exchange or to another person at price $ 10.53 per share. | 01 Jul 2025 | 25,000 | 2,270,672 | - | 10.5 | 263,250 | Common Stock |
Liquidia Corp | Dana Boyle | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,000 | 188,361 (0%) | 0% | 0 | Common Stock | |
Liquidia Corp | Sarah Krepp | Chief Human Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,000 | 145,172 (0%) | 0% | 0 | Common Stock | |
Rush Street Interactive In... | Mattias Stetz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 14.81 per share. | 01 Jul 2025 | 25,000 | 346,051 | - | 14.8 | 370,145 | Class A Common Stock |
Rush Street Interactive In... | Mattias Stetz | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 01 Jul 2025 | 25,000 | 321,051 | - | 15 | 375,000 | Class A Common Stock |
Cushman & Wakefield plc | Michelle M. MacKay | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 24,959 | 24,960 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Michelle M. MacKay | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 24,959 | 275,844 (0%) | 0% | 0 | Ordinary Shares | |
Core & Main Inc - Ordinary... | Robyn Bradbury | Chief Financial Officer | 01 Jul 2025 | 24,957 | 0 | - | - | Class B Common Stock and Limited Partnership Interests | ||
Core & Main Inc - Ordinary... | Robyn Bradbury | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2025 | 24,957 | 24,957 | - | - | Class B Common Stock and Limited Partnership Interests | |
Core & Main Inc - Ordinary... | Robyn Bradbury | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2025 | 24,957 | 162,447 | - | - | Class B Common Stock and Limited Partnership Interests | |
Core & Main Inc - Ordinary... | Robyn Bradbury | Chief Financial Officer | 01 Jul 2025 | 24,957 | 33,555 | - | 0 | Class A Common Stock | ||
SpringWorks Therapeutics Inc | Lewis-Hall Freda C. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 24,727 | 0 (0%) | 0% | - | Common Stock | |
SpringWorks Therapeutics Inc | Alan Fuhrman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 24,727 | 0 (0%) | 0% | - | Common Stock | |
SIGA Technologies Inc | Daniel J. Luckshire | Executive VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 24,193 | 287,410 (0%) | 0% | 0 | Common Stock, par value $.0001 per share | |
SIGA Technologies Inc | Daniel J. Luckshire | Executive VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 24,193 | 0 | - | - | Restricted Stock Units | |
Aware Inc. | Peter R. Faubert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 23,993 | 136,425 (0%) | 0% | 0 | Common Stock | |
Sight Sciences Inc | Paul Badawi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.15 per share. | 01 Jul 2025 | 23,637 | 5,986,943 | - | 4.2 | 98,141 | Common Stock |
Williams Companies | Chad J. Zamarin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 23,607 | 23,607 | - | - | Restricted Stock Units | |
Core Scientific Inc - Ordi... | Sullivan Taylor Adam | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.07 per share. | 01 Jul 2025 | 23,508 | 4,383,553 | - | 17.1 | 401,282 | Common Stock |
Aware Inc. | Gary Evee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 23,490 | 99,557 (0%) | 0% | 0 | Common Stock | |
Brighthouse Financial Inc | Myles J. Lambert | EVP,Chief Mktg.& Dist. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 23,468 | 50,845 (0%) | 0% | - | Common Stock | |
Brighthouse Financial Inc | Myles J. Lambert | EVP,Chief Mktg.& Dist. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 23,468 | 0 | - | - | Restricted Stock Units | |
Evolent Health Inc - Ordin... | Jonathan D. Weinberg | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 23,394 | 254,179 (0%) | 0% | 0 | Class A Common Stock | |
Lantronix Inc | Saleel Awsare | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 23,295 | 297,666 (1%) | 0% | 0 | Common Stock | |
Lantronix Inc | Saleel Awsare | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 23,295 | 46,599 | - | - | Restricted Stock Units | |
Equity Residential - REIT | David J. Neithercut | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 23,277 | 23,277 | - | - | Non-qualified Stock Option (Right to Buy) | |
M&T Bank | Rene F. Jones | Director, Chairman of the Board and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 197.47 per share. | 01 Jul 2025 | 23,265 | 93,618 (0%) | 0% | 197.5 | 4,594,140 | Common Stock |
Telos Corp | Edward Hutchinson Robbins | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. | 01 Jul 2025 | 23,252 | 430,445 | - | 3.1 | 72,546 | Common Stock |
PMV Pharmaceuticals Inc | Robert Ticktin | General Counsel & COO | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 01 Jul 2025 | 23,151 | 98,695 | - | 1.1 | 24,651 | Common Stock |
NetApp | Cesar Cernuda | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 23,142 | 23,142 | - | - | Restricted Stock Unit | |
PubMatic Inc - Ordinary Sh... | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 23,042 | 138,255 | - | - | Restricted Stock Unit | |
Pagaya Technologies Ltd - ... | Evangelos Perros | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 22,766 | 136,594 | - | - | Restricted Stock Unit | |
Pagaya Technologies Ltd - ... | Evangelos Perros | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 22,766 | 95,625 | - | 0 | Class A Ordinary Share | |
SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 22,760 | 0 | - | - | Stock Option (Right to Buy) | |
Southern States Bancshares... | Brent David Hitson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 22,658 | 0 | - | - | Common Stock, par value $5.00 per share | |
Foot Locker Inc | Giovanna Cipriano | SVP & Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.60 per share. | 01 Jul 2025 | 22,383 | 116,278 (0%) | 0% | 21.6 | 483,473 | Common Stock |
Foot Locker Inc | Giovanna Cipriano | SVP & Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 22,383 | 0 | - | - | Employee Stock Option (right to buy) | |
Foot Locker Inc | Giovanna Cipriano | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 24.90 per share. | 01 Jul 2025 | 22,383 | 93,895 (0%) | 0% | 24.9 | 557,337 | Common Stock |
Aware Inc. | John S. Stafford | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 22,315 | 5,082,884 (23%) | 0% | 0 | Common Stock | |
eBay | Jordan Sweetnam | SVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 75.04 per share. | 01 Jul 2025 | 22,207 | 22,206 (0%) | 0% | 75.0 | 1,666,413 | Common Stock |
Boston Scientific | Jonathan R. Monson | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 22,173 | 22,173 | - | - | Stock Option (Right to Buy) | |
ZoomInfo Technologies Inc. | James Roth | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 22,059 | 85,154 | - | - | Common Stock | |
ZoomInfo Technologies Inc. | James Roth | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 22,059 | 154,412 | - | - | Restricted Stock Units | |
Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 5.10 per share. | 01 Jul 2025 | 22,000 | 1,298,391 (1%) | 0% | 5.1 | 112,207 | Common Stock |
Organon & Co. | Ramona A. Sequeira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,890 | 21,890 | - | - | Phantom Stock | |
Starz Entertainment Corp. | Alison Hoffman | President of Starz Networks | Sale or transfer of securities back to the company at price $ 15.82 per share. | 01 Jul 2025 | 21,844 | 76,141 | - | 15.8 | 345,572 | Common Shares |
Arq Inc | Julian Alexander McIntyre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,828 | 58,978 (0%) | 0% | 0 | Common Stock | |
Plug Power Inc | Gary K. Willis | Director | Grant, award, or other acquisition of securities at price $ 1.49 per share. | 01 Jul 2025 | 21,812 | 583,378 (0%) | 0% | 1.5 | 32,500 | Common Stock |
NetApp | Wissam G. Jabre | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,696 | 21,696 | - | - | Restricted Stock Unit | |
SeaStar Medical Holding Corp | Eric Schlorff | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 21,667 | 98,517 | - | 0 | Common Stock, par value $0.0001 per share | |
SeaStar Medical Holding Corp | Eric Schlorff | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 21,667 | 0 | - | - | Restricted Stock Unit | |
Etsy Inc | Joshua G. Silverman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.62 per share. | 01 Jul 2025 | 21,666 | 84,340 (0%) | 0% | 10.6 | 230,093 | Common Stock |
Etsy Inc | Joshua G. Silverman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 21,666 | 1,463,948 | - | - | Employee Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Bhavesh Ashar | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 21,654 | 0 | - | - | Performance Share Units | |
SpringWorks Therapeutics Inc | Cassidy James | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 21,654 | 0 | - | - | Performance Share Units | |
Acco Brands Corporation | John Peters | SVP ACCO Brands, Pres. No. Ame | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,448 | 21,448 | - | - | Restricted Stock Units | |
PubMatic Inc - Ordinary Sh... | Paulina Klimenko | CHIEF GROWTH OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 21,335 | 59,927 | - | 0 | Class A Common Stock | |
SM Energy Co | Herbert Vogel S. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 21,077 | 21,076 | - | - | Restricted Stock Units | |
SM Energy Co | S. Vogel Herbert | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 21,077 | 519,698 (0%) | 0% | - | Common Stock, $.01 Par Value | |
Lifevantage Corporation | Steven R. Fife | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.39 per share. | 01 Jul 2025 | 21,064 | 611,307 (4%) | 0% | 13.4 | 282,047 | Common Stock |
Viridian Therapeutics Inc | Arlene M. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
Viridian Therapeutics Inc | Jeffrey R. Ajer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
Viridian Therapeutics Inc | Jennifer K. Moses | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
Viridian Therapeutics Inc | Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
Viridian Therapeutics Inc | Sarah Gheuens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
DocuSign Inc | Allan Thygesen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 77.26 per share. | 01 Jul 2025 | 20,685 | 163,298 (0%) | 0% | 77.3 | 1,598,123 | Common Stock |
Starz Entertainment Corp. | Alison Hoffman | President of Starz Networks | Sale or transfer of securities back to the company at price $ 16.07 per share. | 01 Jul 2025 | 20,650 | 97,985 | - | 16.1 | 331,846 | Common Shares |
Etsy Inc | Joshua G. Silverman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 20,562 | 74,046 (0%) | 0% | 0 | Common Stock | |
PLAYSTUDIOS Inc - Ordinary... | Agena Joel | General Counsel | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 01 Jul 2025 | 20,490 | 95,301 | - | 1.3 | 27,252 | Class A Common Stock |
Riot Platforms Inc | Stephen Howell | COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.27 per share. | 01 Jul 2025 | 20,345 | 802,785 (3%) | 0% | 11.3 | 229,288 | Common Stock |
Palo Alto | Zuk Nir | Director, EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 198.53 per share. | 01 Jul 2025 | 20,299 | 3,267,816 (3%) | 0% | 198.5 | 4,030,001 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.